ARTICLE | Company News
Imgenex, GZMO reagents deal
February 5, 2001 8:00 AM UTC
Imgenex (San Diego, Calif.) will produce monoclonal antibodies as research reagents against a number of angiogenesis protein targets provided by Genzyme Molecular Oncology (GZMO). GZMO will have right...